What Is HPLC and How Does It Work for Peptides?
High-Performance Liquid Chromatography (HPLC) separates a mixture of chemical compounds as they flow through a stationary phase column under high pressure. For peptide analysis, reversed-phase HPLC (RP-HPLC) is the standard method: the column contains a hydrophobic stationary phase (typically C18), and an aqueous/organic mobile phase gradient (usually water/acetonitrile with ion-pairing agents) is used to elute the peptide and its impurities at different retention times based on their hydrophobicity.
As components exit the column, they pass through a UV detector. Peptides absorb UV light — primarily at 210–220nm (due to the peptide bond) and at higher wavelengths for aromatic-containing peptides. The detector records a signal trace (the chromatogram) showing peaks corresponding to each component, with peak area proportional to the amount of each compound.
What Does "99% HPLC Purity" Actually Mean?
When a CoA says "purity 99.2% (HPLC)," it means: of all the UV-absorbing material detected in the HPLC run, 99.2% was accounted for by the main product peak. The remaining 0.8% is distributed across other peaks — which could be truncated synthesis sequences (missing one or more amino acids), oxidation products, dimerization products, or residual protecting groups not removed during deprotection.
This percentage method has limitations: it only detects UV-absorbing species. If there are impurities that don't absorb UV at the detection wavelength, they will be missed. For most peptide applications, this is an acceptable tradeoff given the method's speed and reproducibility, but it's important to understand what the number represents.
Reading a Peptide HPLC Chromatogram
When you receive a CoA with an HPLC chromatogram, look for:
- The main peak: Should be the dominant peak, clearly separated from others, with a sharp profile. The integration percentage should match the stated purity.
- Impurity peaks: Small peaks on either side of the main peak. Note their relative sizes. A single impurity at 0.5% is different from 10 impurities each at 0.1% — the former suggests one specific synthesis byproduct, while the latter suggests a broader quality issue.
- Baseline: The baseline before and after the main peak should return to near-zero. A raised baseline between peaks may indicate co-eluting impurities.
- Retention time: Each lot's main peak should elute at approximately the same retention time. Large deviations from what you've seen on previous lots' CoA documents may indicate a different compound or significant formulation changes.
What HPLC Cannot Tell You — And Why This Matters for Injectable Peptides
This is the most important section of this article. HPLC purity is necessary but not sufficient for injectable peptide safety. There are critical quality attributes HPLC cannot measure:
Endotoxin Contamination
Bacterial endotoxins (lipopolysaccharides from gram-negative bacteria) are the primary safety risk for injectable peptides. A peptide can be 99.9% pure by HPLC and be dangerously contaminated with endotoxins. Endotoxins don't absorb UV light and are not detected by HPLC. They are only detected by LAL (Limulus Amebocyte Lysate) testing. This is why endotoxin data is non-negotiable for any injectable peptide CoA — a purity number without endotoxin data is an incomplete safety assessment.
Sequence Identity
HPLC confirms that your peptide is pure — but it doesn't confirm what it's pure of. A perfectly pure preparation of the wrong peptide would show a single, sharp, high-purity peak by HPLC. Mass spectrometry is required to confirm that the molecular weight matches the correct peptide sequence. HPLC and MS together provide purity and identity confirmation; neither alone is sufficient.
Residual Solvents
SPPS peptide synthesis uses organic solvents including DMF, DCM, and acetonitrile that can remain in the final product. These are not detected by UV-based HPLC. Residual solvent analysis by gas chromatography (GC-headspace) is required per ICH Q3C.
Sterility
HPLC does not test for microbial contamination. Sterility testing or sterile filtration data is required for injectable-grade preparations, separate from purity analysis.
Why ≥99% Is the Standard for Injectable Peptide API
USP peptide monographs and pharmaceutical compounding standards generally specify ≥98–99% purity for injectable peptide API. The 99% minimum provides a practical safety margin: at 99% purity, the maximum impurity load is 1% — meaning 10mg/g of the preparation is unknown impurities. For lower purity specifications (95–97%), impurity loads of 30–50mg/g represent a clinically meaningful unknown risk for injection patients, particularly for peptides administered daily or sub-daily.
Frequently Asked Questions
Reading the Chromatogram: What You're Actually Looking At
An HPLC CoA without the chromatogram image is incomplete documentation. The chromatogram — the graphical output of the HPLC run — shows the separation of compounds in your peptide sample as peaks across time. The main peak (your peptide of interest) should dominate the chromatogram, with minimal satellite peaks representing impurities. A clean chromatogram shows a single dominant peak with a well-defined Gaussian shape and baseline resolution from any neighboring peaks.
When reviewing a chromatogram, look for: the integration report showing each peak's area percentage (purity = main peak area ÷ total peak area × 100), the retention time of the main peak (which should be consistent across lots from the same supplier), and the number and size of impurity peaks. A purity percentage cited without the supporting chromatogram leaves you unable to verify whether that number represents a clean separation or a questionable integration decision.
Mass Spectrometry: The Companion Test HPLC Cannot Replace
HPLC purity testing measures how much of a sample is your peptide of interest — but it cannot confirm that the dominant compound IS your peptide. This is where mass spectrometry (MS or LC-MS) becomes essential. Mass spectrometry determines the molecular weight of the compounds in your sample, which, when matched against the expected molecular weight of the target peptide, confirms identity. HPLC tells you you have a pure sample; mass spec tells you it's the right molecule.
For peptide API purchasing, always request both analytical tests. A CoA with only HPLC data — however impressive the purity percentage — cannot confirm that you've received semaglutide rather than a structurally similar peptide with similar chromatographic properties. For complex peptides with multiple disulfide bonds (like cyclic peptides or larger therapeutic peptides), MS/MS fragmentation data that confirms the peptide sequence provides even stronger identity verification.
Interpreting Endotoxin Results
Bacterial endotoxins (lipopolysaccharides from gram-negative bacteria) are perhaps the most critical safety parameter in injectable peptide API. The Limulus Amebocyte Lysate (LAL) test quantifies endotoxin content in EU/mg (endotoxin units per milligram). For injectable compounding, a result below 1 EU/mg is the standard threshold; for intrathecal use, the limit drops to 0.1 EU/mg. Any endotoxin result at or above the threshold must be treated as a non-conforming lot — do not compound from this material.
Some suppliers report endotoxin results only as "pass/fail" without the quantitative value. While a pass result is acceptable, a quantitative result provides better information — particularly if you need to compare lots across time or investigate a result near the threshold. When evaluating a new supplier, request quantitative endotoxin data to establish a baseline for their typical lot performance. Suppliers who consistently deliver results far below the 1 EU/mg threshold are demonstrating genuine manufacturing quality, not just threshold compliance.
What does HPLC purity mean for peptide API?
HPLC purity represents the proportion of the main peptide peak relative to all UV-detected peaks. 99% means the main product is 99% of detected area, with 1% in impurity peaks.
What does HPLC testing NOT tell you?
HPLC cannot detect endotoxins, confirm sequence identity, measure residual solvents, or assess sterility. All four require separate testing methods. HPLC alone is never sufficient quality documentation for injectable peptide API.
Why is ≥99% the standard for injectable peptides?
At ≥99% purity, maximum impurity load is 10mg/g — a clinically acceptable unknown. Lower specifications (95–97%) allow 30–50mg/g of unknown impurities in a preparation injected into patients daily.
What is a "clean" HPLC chromatogram for a peptide?
A single dominant main peak, well-resolved from adjacent impurities, with small (<0.5% each) or no visible impurity peaks, near-zero baseline, and symmetric peak shape. The main peak integration should equal the stated purity percentage.